Nuclear Medicine is a division of the department of Molecular & Medical Pharmacology. Located in the Ahmanson Biological Imaging Clinic, UCLA's clinical nuclear medicine services are provided through five state-of-the-art Positron Emission Tomography (PET) and Positron Emission Tomography/Computed Tomography (PET/CT) units. PET technology can detect disease processes early -- often before symptoms appear -- giving physicians an expeditious lead in treating cancer, heart disease and other medical conditions.
Spanning the spectrum from "bench to bedside," the research activities of UCLA's nuclear medicine include detecting and staging a wide range of cancers, identifying causes of heart failure and developing cost-effective treatments, exploring human brain functions and interactions, and merging molecular diagnostics with molecular therapies, among other valuable applications.